Phyllodes Tumour Recurrence Risk Assessment

Welcome to the Singapore General Hospital's Department of Pathology risk assessment tool for estimating a person’s recurrence free likelihood following a histologic diagnosis of breast phyllodes tumour.
This tool is based on a study undertaken at the Singapore General Hospital (Tan PH et al. J Clin Pathol. 2012 Jan;65(1):69-76.)
This tool was designed for use by healthcare professionals. If you are not a healthcare professional, you are encouraged to discuss the results with your doctor.   Please read the SGH Nomogram Terms of Use before proceeding with this tool.
Detailed information on this risk assessment tool is available [Definitions for nomogram].

• Risk assessment tool

Does the tumor show stromal cytologic atypia	None or mild	Moderate		Marked
How many mitoses are visible per 10 high powered fields?	Mitoses per 10 hpf
Is there stromal overgrowth seen?	Absent	Present
Are the margins histologically involved (positive)?	Negative	Positive

SGH Nomogram Terms of Use | Privacy Policy